Tower Research Capital »

Immunovant shares owned by Tower Research Capital

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $17k 512 32.31
2023-09-30 $370k 9.6k 38.39
2023-06-30 $34k 1.8k 18.97
2023-03-31 $321k 21k 15.41
2022-12-31 $58k 3.2k 17.89
2022-09-30 $65k 12k 5.52
2022-06-30 $22k 5.8k 3.82
2022-03-31 $57k 10k 5.47
2021-12-31 $46k 7.9k 5.75
2021-09-30 $88k 10k 8.58
2021-06-30 $45k 4.1k 11.11
2021-03-31 $92k 5.7k 16.05
2020-12-31 $112k 2.5k 45.75
2020-09-30 $140k 3.9k 35.35
2020-06-30 $26k 1.1k 24.64